We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANNX icon
251
Annexon
ANNX
$841M
$10.1M 0.06%
+2,053,459
New +$10.6M
INDA icon
252
iShares MSCI India ETF
INDA
$6.77B
$9.95M 0.06%
84,000
-72,370
-46% -$3.83M
PLD icon
253
Prologis
PLD
$137B
$9.9M 0.06%
88,162
-3,056
-3% -$339K
VRDN icon
254
Viridian Therapeutics
VRDN
$2.18B
$9.75M 0.06%
749,804
+469,804
+168% +$6.5M
CYTK icon
255
Cytokinetics
CYTK
$10.9B
$9.71M 0.06%
179,200
-313,829
-64% -$18.9M
ULTA icon
256
Ulta Beauty
ULTA
$20.7B
$9.7M 0.06%
25,138
+1,253
+5% +$509K
T icon
257
AT&T
T
$167B
$9.63M 0.06%
503,692
+35,723
+8% +$621K
PTGX icon
258
Protagonist Therapeutics
PTGX
$8.72B
$9.49M 0.06%
273,818
-86,182
-24% -$2.52M
ITW icon
259
Illinois Tool Works
ITW
$81.9B
$9.37M 0.06%
39,563
+1,678
+4% +$415K
TMUS icon
260
T-Mobile US
TMUS
$190B
$9.35M 0.06%
53,062
-12,163
-19% -$2.04M
BLK icon
261
Blackrock
BLK
$165B
$9.35M 0.06%
11,870
+1,245
+12% +$971K
ALGN icon
262
Align Technology
ALGN
$12B
$9.28M 0.06%
38,450
+33,491
+675% +$9.32M
SHOP icon
263
Shopify
SHOP
$165B
$9.22M 0.06%
139,492
+1,513
+1% +$100K
TWLO icon
264
Twilio
TWLO
$29.5B
$9.21M 0.06%
162,198
+120,595
+290% +$7.11M
ARES icon
265
Ares Management
ARES
$28.8B
$9.17M 0.06%
68,781
-53,092
-44% -$7.25M
COP icon
266
ConocoPhillips
COP
$141B
$9.13M 0.06%
79,843
-180
-0.2% -$21.9K
PYPL icon
267
PayPal
PYPL
$49.5B
$9.08M 0.06%
156,417
-96,407
-38% -$6.13M
CME icon
268
CME Group
CME
$92.3B
$9.07M 0.06%
46,139
-53,469
-54% -$11M
EXAS
269
DELISTED
Exact Sciences
EXAS
$8.98M 0.05%
212,527
+15,774
+8% +$868K
PLRX icon
270
Pliant Therapeutics
PLRX
$66.9M
$8.96M 0.05%
833,216
+285,216
+52% +$3.68M
UPS icon
271
United Parcel Service
UPS
$96B
$8.94M 0.05%
65,362
+3,989
+6% +$571K
IBN icon
272
ICICI Bank
IBN
$107B
$8.93M 0.05%
310,000
+1,000
+0.3% +$26.8K
HR icon
273
Healthcare Realty
HR
$7.46B
$8.91M 0.05%
+540,764
New +$8.27M
IDXX icon
274
Idexx Laboratories
IDXX
$43.9B
$8.81M 0.05%
18,084
-7,454
-29% -$3.74M
AMT icon
275
American Tower
AMT
$77.7B
$8.54M 0.05%
43,912
+8,186
+23% +$1.53M
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.